Reliance Group Stocks Erode Over Rs 40,000 Crore Market-Cap
 070524.jpg?downsize=1010:568 "Reliance Group Stocks Erode Over Rs 40,000 Crore Market-Cap")
Reliance Group companies eroded over Rs 40,000 crore market-cap on Monday, due to broad-based weakness in the markets. Market-cap of these companies declined Rs 40,511.91 crore to Rs 17.46 lakh crore.
All stocks declined, with the Sterling & Wilson Renewable Energy Ltd. leading losses. Just Dial Ltd. and Balaji Telefilms Ltd. were other top losers.
Reliance Group's flagship company, Reliance Industries Ltd. was the third biggest loser in the NSE Nifty 50. In terms of point contribution, Reliance Industries is the second top dragger in the NSE Nifty 50. Reliance Industries holds the second highest weightage in the benchmark index.
With Monday's decline, Reliance Industries declined for two days in a row. Except Thursday's session the stock fell for three days in a row. On Monday, Reliance Industries' market cap fell Rs 35,319.49 crore to Rs 15.89 lakh crore.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
